# SANM (Sanmina  Corp) Stock Analysis — 2026-05-22

> Sanmina has been transformed by the ZT Systems acquisition, with cloud/AI infrastructure now comprising 62% of sales and Q2 FY26 revenue surging 102% YoY to $4.01B. The stock has rallied ~187% from its 52-week low to trade within 8% of its all-time high, pricing in significant AI-driven manufacturin...

- Verdict: **Sell**
- Price at analysis: $234.36
- 1Y price target: $215.00 (-8.3% implied)
- 3Y price target: $250.00 (+6.7% implied)
- Technicals: RSI 64, MACD bullish
- Source: https://stockquantai.com/research/sanm/2026-05-22

## Executive Summary

Sanmina has been transformed by the ZT Systems acquisition, with cloud/AI infrastructure now comprising 62% of sales and Q2 FY26 revenue surging 102% YoY to $4.01B. The stock has rallied ~187% from its 52-week low to trade within 8% of its all-time high, pricing in significant AI-driven manufacturing growth. The AMD partnership and rapid revenue scaling are real catalysts, but operating margins remain thin (6.4% non-GAAP) and forward guidance has repeatedly disappointed — Q3 guidance came in $170M below consensus and a prior quarter triggered a 22% selloff on similar guidance issues.

The key tension: SANM is executing operationally but trading at ~25x trailing earnings and ~35x on some measures, while third-party fair value estimates have been TRIMMED from $197.50 to $168.75 — well below the current $234 price. ZT Systems carries lumpy hyperscaler revenue with profit-sharing arrangements that compress margin capture, and projected cash burn of $98-288M flagged by skeptics raises capital efficiency concerns. The $600M buyback authorization helps, but does not fully offset valuation risk.

Verdict: Neutral with a downside bias. The fundamentals are strong but already reflected in price, AI customer concentration creates lumpy demand, and the recent pattern of guidance disappointments suggests upside surprise is limited from here. We see modest downside over 12 months as multiple compresses, with 3-year value supported by continued AI buildout — but no asymmetric upside at this entry point.

## Price Targets

| Horizon | Price | Implied Growth |
|---|---|---|
| 1 Year | $215.00 | -8.3% |
| 3 Year | $250.00 | +6.7% |

## Scenarios

| Scenario | 1Y Price | 3Y Price | Thesis |
|---|---|---|---|
| Hyper Bull | $320.00 | $450.00 | AI capex supercycle accelerates further, ZT Systems wins additional hyperscaler customers beyond AMD, and operating margins expand toward 8%+ as scale benefits kick in. EPS approaches $15+ with multiple expansion to 25-30x as the market reclassifies SANM as an AI infrastructure pure-play. Buybacks aggressively executed at attractive prices. |
| Bull | $280.00 | $360.00 | Revenue continues 30-50% YoY growth through FY27, ZT execution remains strong, and Sanmina captures incremental AI workloads. EPS reaches $13-14 with modest multiple expansion. Diversified end markets provide cushion if AI lumpiness creates short-term volatility. |
| Neutral | $230.00 | $270.00 | Strong revenue growth continues but at decelerating pace; margins remain capped by profit-sharing arrangements. Multiple compresses as guidance volatility persists and AI capex enthusiasm cools. EPS grows to $11-12 but multiple drifts to 20-22x. Buybacks support floor but don't drive substantial upside given near-peak valuation. |
| Bear | $175.00 | $195.00 | AI capex normalizes faster than expected, hyperscaler customers extract pricing concessions, and margin compression accelerates. Guidance disappointments continue triggering multiple compression. Stock re-rates to 15-18x EPS aligning with traditional EMS peers like Jabil. Fair value estimates of $168 prove prescient. |
| Hyper Bear | $135.00 | $130.00 | AI infrastructure spending materially decelerates by late 2026, AMD partnership terms renegotiate against SANM, and ZT Systems integration issues surface. Combined with broader recession, EPS collapses to $7-8 and multiple drops to 15x. EMS sector de-rates broadly. |

## Key Metrics

- Market Cap: $12.39B
- P/E Ratio: ~25x (trailing); ~35x on some measures
- P/S Ratio: ~0.8x
- Revenue: $4.01B (Q2 FY26); ~$14B+ annualized
- Net Income: N/A
- EPS: $3.16 (Q2 FY26 non-GAAP); $1.70 GAAP
- Dividend Yield: N/A
- Beta: N/A
- 52-Week High: $255.22
- 52-Week Low: $81.69
- Short Interest: N/A

## Micro Analysis

Sanmina's transformation via ZT Systems acquisition has dramatically reshaped the revenue mix toward AI/cloud (62%), but margin structure and guidance volatility temper enthusiasm at current valuation.

- **ZT Systems Driving Hypergrowth**: Q2 FY26 revenue $4.01B (+102% YoY), with ZT contributing $1.88B. IMS revenue up 123.5% YoY, CPS up 12.2%. Cloud/AI now 62% of sales — a structural shift, not a cyclical bump.
- **Thin and Pressured Margins**: Non-GAAP operating margin 6.4%, gross margin only 9.0%. ZT Systems hyperscaler business carries profit-sharing arrangements with AMD that limit margin expansion even as revenue scales. GAAP operating margin just 3.9%.
- **Repeated Guidance Disappointments**: Q1 FY26 print triggered a 22% single-day drop on weak Q2 guidance ($3.1-3.4B vs $3.52B expected). Q2 again beat but next-quarter guide of $3.35B came in 4.7% below consensus. Pattern suggests outsized AI revenue is being pulled forward into individual quarters.
- **Valuation Stretched vs. Fair Value Estimates**: Third-party fair value cut from $197.50 to $168.75 — implying ~28% downside. Stock trades at roughly 23-25x normalized EPS, expensive for an EMS provider with mid-single-digit margins, even with AI mix-shift.
- **Capital Return and Balance Sheet**: $1.58B cash position with $600M buyback authorization is supportive. Cash flow from ops of $399M in Q2 demonstrates working capital discipline. However, analysts flag $98-288M projected cash burn risk tied to working capital needs of ZT ramp.
- **Customer Concentration Risk**: AMD is now a critical partner via the ZT acquisition. While the AMD relationship anchors the AI thesis, single-customer dependence in cloud AI creates lumpy demand and pricing risk if hyperscaler capex normalizes.

## Macro Analysis

AI infrastructure buildout remains a powerful tailwind, but supply chain pressures, potential capex normalization, and EMS sector competitiveness create offsetting risks.

- **AI Capex Supercycle**: Hyperscaler AI capex continues to expand, benefiting EMS players supplying compute racks and infrastructure. SANM is now positioned as a preferred AMD manufacturing partner — a direct beneficiary.
- **Supply Chain & Component Constraints**: Q2 commentary highlighted supply chain pressures even amid revenue strength. Component availability and cost inflation can erode already-thin EMS margins.
- **Aerospace/Defense and Medical Diversification**: Core Sanmina ex-ZT grew only 7.3% YoY — meaningful but unspectacular. Defense PCB and medical CDMO end markets offer steady but slower-growth ballast.
- **Interest Rate Environment**: Higher rates pressure cyclical industrial customers and limit multiple expansion for capital-intensive manufacturing names. Working capital financing costs also matter for a high-volume EMS player.
- **EMS Competitive Landscape**: Flex, Jabil, Celestica all chasing the same AI infrastructure dollars. Celestica's stock has run similarly. The risk is hyperscaler purchasing power compresses EMS margins industry-wide over time.

## Revenue Opportunities

- **AMD Cloud AI Partnership** (potential: high): Preferred manufacturing partner status for AMD's cloud AI solutions, with the ZT Systems business positioned to capture multi-year AI rack-scale demand.
- **Texas Manufacturing Capacity Expansion** (potential: medium): Larger Texas facility coming online — onshoring tailwind and capacity for AI-related contract wins, though significant capex commitment.
- **Medical Device CDMO Growth** (potential: medium): Profiled as a key player in a $354B+ medical CDMO market by 2033, with IVD contract manufacturing projected at 10.4% CAGR.
- **Aerospace & Defense PCBs** (potential: medium): Aerospace PCB market projected to reach $1.9B by 2034; SANM positioned among leading suppliers with defense backlog visibility.
- **Share Buyback Program** (potential: low): $600M authorization supports per-share metrics and signals management confidence; meaningful relative to $12.4B market cap.

## Headwinds

- **Stretched Valuation Near 52-Week High** (severity: high): Stock trades within 8% of 52-week high after a 187% run from the low. Third-party fair value estimates of $168.75 imply ~28% downside. Limited margin for error.
- **Guidance Disappointment Pattern** (severity: high): Multiple quarters of beating prints but guiding below consensus, including a 22% single-day selloff in January 2026. AI revenue lumpiness creates ongoing quarter-to-quarter risk.
- **Margin Compression from Profit-Sharing** (severity: medium): ZT Systems hyperscaler revenue carries profit-sharing terms with AMD, capping operating margin expansion despite massive revenue growth. Mix-shift may dilute, not expand, margins.
- **Customer Concentration** (severity: medium): Heavy dependence on AMD-related hyperscaler demand. Any pullback in hyperscaler capex or competitive shift could materially impact revenue.
- **Working Capital and Cash Burn Risk** (severity: medium): Projected $98-288M cash burn flagged by analysts to fund AI ramp; capex-intensive expansion could pressure free cash flow generation despite strong ops cash flow.

## Tailwinds

- **AI Infrastructure Supercycle** (strength: high): Hyperscaler capex expanding rapidly; SANM/ZT is a direct beneficiary as a preferred AMD manufacturing partner for AI compute infrastructure.
- **Onshoring/Reshoring Tailwind** (strength: medium): Geopolitical pressure to onshore advanced manufacturing favors US-based EMS providers with Texas/Mexico capacity expansion.
- **Strong Cash Generation & Buyback** (strength: medium): $399M operating cash flow in Q2 and $600M buyback authorization provide downside support and per-share earnings accretion.
- **Diversified End Markets** (strength: medium): Aerospace, defense, and medical CDMO segments provide non-cyclical ballast against AI/cloud volatility.

## Disclaimer

This report was generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always conduct your own research and consult a licensed financial advisor before making investment decisions.